Showing 1 - 10 of 4,248
Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These...
Persistent link: https://www.econbiz.de/10014047447
India has one of the most advanced pharmaceutical industries among developing countires. Yet India is critically dependent on China for supplies of build drugs and drug intermediates with China accounting for about two-thirds of the total imports. In the early 1990s, China was relatively a minor...
Persistent link: https://www.econbiz.de/10013466963
Persistent link: https://www.econbiz.de/10000646527
Persistent link: https://www.econbiz.de/10003756813
Persistent link: https://www.econbiz.de/10003344043
Persistent link: https://www.econbiz.de/10011378658
Persistent link: https://www.econbiz.de/10002960708
Persistent link: https://www.econbiz.de/10001677413
Persistent link: https://www.econbiz.de/10001040536
This paper uses macro-level data between 1997 and 2008 to evaluate the effects of China's pharmaceutical price regulations. We find that these regulations had short-run effects on medicine price indices, reducing them by less than 0.5 percentage points. The effects could have been slightly...
Persistent link: https://www.econbiz.de/10013066440